Search
Now showing items 1-8 of 8
Article
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study
| Date Issued:
2018 | Copyright:
open access
Article
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial
| Date Issued:
2021 | Copyright:
restricted access
Article
The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil
| Date Issued:
2007 | Copyright:
open access
Papers presented at events
Integrase inhibitor-based antiretroviral treatment does not increase the risk of TB-IRIS in people with HIV treated for tuberculosis: findings from the Reflate TB2 randomized trial
| Date Issued:
2023 | Copyright:
open access
Article
At the crossroads between early or delayed antiretroviral therapy initiation during tuberculosis/human immunodeficiency virus coinfection
| Date Issued:
2014 | Copyright:
open access
Article
Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries
| Date Issued:
2019 | Copyright:
open access
Article
Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial
| Date Issued:
2024 | Copyright:
open access
Article
Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease
| Date Issued:
2013 | Copyright:
open access